ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Bradycardia | 02.03.02.002 | 0.001013% | | Not Available |
Bronchitis | 22.07.01.001; 11.01.09.001 | 0.000338% | | |
Bronchospasm | 22.03.01.004; 10.01.03.012 | 0.000338% | | |
Burning sensation | 17.02.06.001; 08.01.09.029 | 0.000901% | | Not Available |
C-reactive protein increased | 13.09.01.007 | 0.000225% | | Not Available |
Cardiac failure | 02.05.01.001 | - | - | |
Cardiovascular disorder | 24.03.02.009; 02.01.01.001 | 0.000059% | | Not Available |
Cataract | 06.06.01.001 | 0.006866% | | |
Cellulitis | 23.09.01.001; 11.02.01.001 | - | - | Not Available |
Cerebral infarction | 24.04.06.002; 17.08.01.004 | 0.000338% | | Not Available |
Cerebrovascular accident | 24.03.05.001; 17.08.01.007 | - | - | |
Chest discomfort | 22.02.08.001; 08.01.08.019; 02.02.02.009 | 0.000450% | | Not Available |
Chest pain | 22.02.08.003; 08.01.08.002; 02.02.02.011 | - | - | Not Available |
Chills | 15.05.03.016; 08.01.09.001 | - | - | |
Choroidal detachment | 06.09.01.003; 12.01.04.006 | 0.000450% | | Not Available |
Coma | 17.02.09.001 | - | - | Not Available |
Compression fracture | 15.08.02.004; 12.04.02.008 | 0.000225% | | Not Available |
Confusional state | 19.13.01.001; 17.02.03.005 | - | - | |
Conjunctival haemorrhage | 24.07.05.001; 06.07.01.001 | 0.001126% | | Not Available |
Conjunctivitis | 11.01.06.012; 06.04.01.002 | 0.000563% | | |
Conjunctivitis allergic | 10.01.04.002; 06.04.01.003 | 0.000563% | | Not Available |
Corneal epithelium defect | 06.06.03.012 | 0.000788% | | Not Available |
Corneal erosion | 06.06.03.003 | - | - | Not Available |
Corneal oedema | 06.04.02.001 | 0.000563% | | Not Available |
Corneal opacity | 06.06.03.005 | 0.000675% | | Not Available |
Corneal scar | 12.01.04.015; 06.06.03.015 | 0.000450% | | Not Available |
Cough | 22.02.03.001 | 0.001801% | | |
Crohn's disease | 10.02.01.005; 07.08.01.015 | 0.000225% | | Not Available |
Death | 08.04.01.001 | - | - | |
Dehydration | 14.05.05.001 | - | - | |